Our Offer

Solv4U Technology Partnerships based on MarinosolvĀ®: the basis for better therapies

Solv4U technology partnerships are the right choice if you aim

  • To enhance the bioavailability of New Chemical Entities (NCEs) for exploratory preclinical studies
  • To re-formulate or re-purpose established off-patent APIs

We focus on your individual needs and consider your requirements for subsequent development stages, such as process up-scaling, intended administration routes and manufacturing.

 

Formulation services at Marinomed start with a feasibility study at reasonable costs and with defined timelines.

Project Outline:

Step 1: Feasibility study

  • Establishment of analytical method
  • Design, prepare and evaluate a defined number of modifications of MarinosolvĀ® formulation with target compound.
  • 6-day stability data
  • Report

Step 2: Formulation development

  • Optimize formulation and evaluate stability
  • Provide non-GMP study medication

Step 3: Development of manufacturing process

Step 4: Tech Transfer to client/CMO

Step 5: License model

 

Further Information on Solv4U (Download):

Susanne Bach, PhD
Senior Manager BD&L
Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg, Austria
+43 2262 90300
office@marinomed.com